Monday, November 21, 2011

DePuy Orthopaedics' International Sales Save 1.5% Decrease in US Sales

Written by Laura Miller | November 15, 2011
DePuy Orthopaedics experienced a 1.5 percent decrease in U.S. sales for the third quarter of 2011, according to a news release from DePuy's parent company, Johnson & Johnson.

The company reported $737 million in U.S. sales for the third quarter and approximately $1.4 billion in worldwide sales. Worldwide sales increased by 5.7 percent over the third quarter of last year. The 1.5 percent decrease in U.S. sales was offset by at 15.3 percent increase in international sales.

Johnson & Johnson's total expenses due to litigation matters was reported as $654 million during the third quarter, with additional costs of $109 million due to the recall of the DePuy ASR Hip, initiated in the summer of 2010. Johnson & Johnson also reported $214 million in costs associated with acquiring spine device company Synthes.

No comments:

Post a Comment